Stenocare
Drug Stores & Pharmacies · Denmark · 51-200 Employees
View Company Info for Free
Overview
Headquarters
DenmarkWebsite
www.stenocare.dkRevenue
$48 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Stenocare
STENOCARE A/S is a Danish company that cultivates, imports, and sells prescription medical cannabis under Denmark's medical cannabis trial scheme. The company operates in several countries, including Denmark, Sweden, Norway, Germany, the UK, and Australia, providing a strong portfolio of prescription medical cannabis products aimed at improving patients' quality of life. STENOCARE is the first Danish company to introduce full-spectrum prescription medical cannabis products to the Nordic market, ensuring quality and consistency through pharmaceutical production. The company is committed to making well-documented and pharmaceutical-grade medical cannabis accessible to both doctors and patients.Explore more
Popular SearchesStenocare A/SStenocareSIC Code 51,512NAICS Code 42,424Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stenocare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Stenocare has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Stenocare
Click to see if Stenocare had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Stenocare is spiking on competitors!
Earning: See what the market has to say on Stenocare recently announced quarterly report
Product Launch: Get notified when Stenocare launches new products
Check if Stenocare has recently received funding, and reach out quickly before it becomes old news!
Stenocare, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Stenocare as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Stenocare is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Stenocare is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Stenocare.
Stenocare Tech Stack
A closer look at the technologies used by Stenocare
See more technologies
Stenocare News & Media
Interim Report First Quarter 2023
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2023 – 31.03.2023. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: ”Stenocare had a busy start of 2023. Progress was made on several fronts despite a relatively uneventful news-floCOMMUNIQUE FROM THE ANNUAL GENERAL MEETING OF STENOCARE
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO On 19 May 2022 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at St. Kannikestræde 19, 1169 Copenhagen K with the following agenda: Agenda: 1. Appointment of a chairman of the meeting 2. Report of the chairman of the board of directors 3. Presentation of the annual report together with a resolution for its adoption 4. Resolution to appropriate theSTENOCARE delivers first product batch to the Danish market
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO Today, Monday May 16, 2022, STENOCARE delivers the first product batch of their THC Oil to the Danish market. This means that the product is once again visible in medicinpriser.dk and that all Danish pharmacies can sell the products starting today. STENOCARE has been working intensely with its Canadian partner, AgMEDICA Bioscience, and with The Danish Medicines Agency to have the new medical cannabis oilNotice to Annual General Meeting in STENOCARE A/S
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO The board of directors hereby convenes the shareholders of STENOCARE to the Annual General Meeting, which will be held: STENOCARE A/S May 19 2022 at 1:00 PM (the doors open at 12:30 PM) at St. Kannikestræde 19 1169 Copenhagen With the following agenda: 1. Appointment of a chairman of the meeting 2. Report of the chairman of the board of directors 3. Presentation of the
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stenocare
Sign Up For FreeTo access detailed company insights
STENOCARE A/S is a Danish company that cultivates, imports, and sells prescription medical cannabis under Denmark's medical cannabis trial scheme. The company operates in several countries, including Denmark, Sweden, Norway, Germany, the UK, and Australia, providing a strong portfolio of prescription medical cannabis products aimed at improving pat... Read More
